BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16094420)

  • 1. Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia.
    Motta M; Rassenti L; Shelvin BJ; Lerner S; Kipps TJ; Keating MJ; Wierda WG
    Leukemia; 2005 Oct; 19(10):1788-93. PubMed ID: 16094420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia.
    Frydecka I; Kosmaczewska A; Bocko D; Ciszak L; Wolowiec D; Kuliczkowski K; Kochanowska I
    Br J Cancer; 2004 May; 90(10):2042-8. PubMed ID: 15138491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
    Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
    Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response.
    Hus I; Schmitt M; Tabarkiewicz J; Radej S; Wojas K; Bojarska-Junak A; Schmitt A; Giannopoulos K; Dmoszyńska A; Roliński J
    Leukemia; 2008 May; 22(5):1007-17. PubMed ID: 18323802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.
    Perry C; Hazan-Halevy I; Kay S; Cipok M; Grisaru D; Deutsch V; Polliack A; Naparstek E; Herishanu Y
    Ann Hematol; 2012 Aug; 91(8):1271-9. PubMed ID: 22349724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells.
    Vilpo J; Hulkkonen J; Hurme M; Vilpo L
    Leukemia; 2002 Sep; 16(9):1691-8. PubMed ID: 12200683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
    Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
    Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 expression in T cells of patients with atopic dermatitis.
    Choi SY; Sohn MH; Kwon BC; Kim KE
    Pediatr Allergy Immunol; 2005 Aug; 16(5):422-7. PubMed ID: 16101935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody.
    Ciszak L; Frydecka I; Wolowiec D; Szteblich A; Kosmaczewska A
    Tumour Biol; 2016 Mar; 37(3):4143-57. PubMed ID: 26490985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.
    Ayukawa H; Matsubara T; Kaneko M; Hasegawa M; Ichiyama T; Furukawa S
    Clin Exp Immunol; 2004 Jul; 137(1):151-5. PubMed ID: 15196256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
    Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
    Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
    Scrivener S; Goddard RV; Kaminski ER; Prentice AG
    Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.